CHEK2 and gastric cancer: The cancer-specific activations of CHEK2 and ATR correspond to the results of the two pathway analyses (Figure 4B and Figure S1) and to the previous study, which demonstrated the functional importance of DDR signaling in gastric cancer cases 38.